focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Based on the research note from H.C.Wainwright & Co that appears on Tiziana's website, regarding Accustem "... its valuation could be fairly reckoned at $280M—10% of the valuation placed upon Genomic Health at the time of its acquisition by EXACT Sciences."
That's not to say it will be valued at that, but I think 10% is a very conservative figure.
Dan.
Noticed that B.Riley Securities in US have set a price target for TLSA of $8. The current price for the ADS share is just over $2 so looking at a fairly substantial increase from here... even the low price target according to wsj.com is over $4, average is $6.
thefly.com/news.php?symbol=TLSA
GL, Dan.
Hi all, just a reminder... on 2nd November Proactive Investors video, Gabriele said 6-7 weeks for Brazil results... Next week is 7 weeks, all we need to do is wait, or buy more like I've done today!
Remember what happened with SNG... very good news really does propel these stocks, especially in the US and now is not the time to sell, it's the time to buy imo.
Dan.
https://presentations.investormeetcompany.com/conferences/5667798d15ea/bigroom
Plenty of news for TLSA in the US prior to stock market opening over there...
newsfilter.io/a/0e85742c983401acfb6a70133b88cdb6
otcdynamics.com/tlsa-tiziana-life-sciences-announces-planned-spin-out-of-stemprinter-into-a-new-publicly-listed-company-accustem-sciences/
globenewswire.com/news-release/2020/09/16/2094353/0/en/Tiziana-Life-Sciences-Announces-Planned-Spin-Out-of-StemPrintER-into-a-New-Publicly-Listed-Company-Accustem-Sciences.html
stocktitan.net/news/TLSA/tiziana-life-sciences-announces-planned-spin-out-of-stem-print-er-95y2gb25gmjt.html
Valhalla14 - Remove the full stop at the end of the link :)
First of all, what a fantastic presentation! This stock is without doubt one to hold for at least a couple of years. There is SO much potential as described in the presentation, it's incredible really!
It seems to me that some investors can't see passed Covid and expect a working product mass manufactured by next week. It simply doesn't work like that.
To me it seems that Al is suggesting end of June as a worst case scenario timeline, so not to overpromise anything. He is one for underpromising and overdelivering as evident by previous RNS'. It wouldn't surprise me if they have a prototype ready sooner than this.
I hear Al say they were originally aiming for £25m fundraising, but massively oversubscribed to £48m, should tell you something. Al's response to the fundraising was honest and straight to the point. They are an innovative company and if they can raise £48m quite easily to work on more successful diagnostics and therapeutics then why the heck not, it means more potential revenue at the end of the day, which is better for those of us that stay in this share longer term.
I did hear a snippet of Al saying that they're working on other testing for Covid, does this mean for children (being the inflammatory problems children have had recently due to Covid?) or are they also creating an antibody test? if so then this could be combined into one testing device (antigen and antibody! Do you have Covid and have you had it?!). These are just my assumptions, although I believe they have the ability to do it so why not?!
I'm waiting for my conservative price target of £3.80 per share to be hit before I profit take (from my average price of 38p), which in my opinion is likely within the next few months. I'll be very happy with that :)
Well done Avacta and GL all, and please please please don't reply to the trolls, it only continues their stupid de-ramping headlines, which is their objective.
Dan.
Not sure if this has been shared yet...
Avacta mentioned in the Daily Mail in between the BT article.
https://www.dailymail.co.uk/money/markets/article-8324607/MARKET-REPORT-BT-bounces-rumours-Openreach-stake-sale.html
Good afternoon all, my very first post on LSE, wooo!
I've been invested in EUA since Oct 19 so considered a fairly new investor by most. I think most of us can agree that this suspension has really highlighted the true value of this stock and how ridiculously underpriced it is. If there is no sale on the table just yet and the stock resumes trading at its current price, I can see some heft buys coming in very quickly, which will likely drive the share price up anyway. So either way this can only be a good thing? Shorter's will be soiling themselves right now I agree, so at least this suspension will likely put them off from shorting this stock for a while. Buys will come in from new and current investors and we'll all see the value of our shares go up.
Would you agree?
This is IMO of course. GLA